2015 European guideline on the management of Chlamydia trachomatis infections

International Journal of STD and AIDS

Volumn 27, Issue 5, 2016, Pages 333-348

  Lanjouw, E ^a   Ouburg, S ^b   de Vries, H J ^c,d   Stary, A ^e   Radcliffe, K ^f   Unemo, M ^g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Infectious Disease Cluster   (Netherlands)

^e Outpatients' Centre for Infectious Venereodermatological Diseases   (Austria)

^f UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^g Örebro University   (Sweden)

Author keywords

antibiotic; Chlamydia trachomatis; diagnosis; Europe; genital; lymphogranuloma venereum; pelvic inflammatory disease; sexually transmitted infection; treatment

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; LEVOFLOXACIN; OFLOXACIN;

ADNEXITIS; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL CONJUNCTIVITIS; BACTERIAL TRANSMISSION; BREAST FEEDING; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL EXAMINATION; CLINICAL FEATURE; ECTOPIC PREGNANCY; ENDOMETRITIS; EPIDIDYMITIS; EPIDIDYMOORCHITIS; EYE INFECTION; FALSE NEGATIVE RESULT; FEMALE INFERTILITY; FITZ HUGH CURTIS SYNDROME; FLUORESCENCE ANALYSIS; FOLLOW UP; HEALTH CARE ACCESS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; LABORATORY DIAGNOSIS; LABORATORY TEST; LYMPHOGRANULOMA VENEREUM; MALE INFERTILITY; MEN WHO HAVE SEX WITH MEN; META ANALYSIS (TOPIC); NEWBORN INFECTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID ANALYSIS; ORCHITIS; OVARY INFLAMMATION; PATIENT CARE; PELVIC INFLAMMATORY DISEASE; PELVIC PERITONITIS; PELVIS PAIN SYNDROME; PERITONITIS; PHARYNGITIS; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCTOCOLITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REACTIVE ARTHRITIS; SALPINGITIS; SCREENING; SEMEN ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUALLY ACQUIRED REACTIVE ARTHRITIS; TUBOOVARIAN ABSCESS; UROGENITAL TRACT INFECTION; CHLAMYDIA INFECTIONS; DISEASE MANAGEMENT; EUROPE; FEMALE; ISOLATION AND PURIFICATION; PUBLIC HEALTH; STANDARDS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CLINICAL LABORATORY TECHNIQUES; DISEASE MANAGEMENT; EUROPE; FEMALE; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH;

EID: 84960102591     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462415618837     Document Type: Article

References (214)

1. W.E.StammChlamydia trachomatis infections of the adults. In: (eds). Sexually transmitted diseases, 4th ed. New York, NY: McGraw Hill, 2008. chap. 32.
2. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2010. http://www.cdc.gov/std/stats11/surv2011.pdf (2011, accessed 15 August 2015)
3. European Centre for Disease Prevention and Control. Chlamydia control in Europe: literature review, http://www.ecdc.europa.eu/en/publications/Publications/chlamydia-control-europe.pdf (2014, accessed 15 August 2015)
4. European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe 2013. http://www.ecdc.europa.eu/en/publications/Publications/sexually-transmitted-infections-europe-surveillance-report-2013.pdf (2015, accessed 15 August 2015)
5. P.W.DielissenD.A.M.TeunissenA.L.M.Lagro-Janssen. Chlamydia prevalence in the general population: Is there a sex difference? A systematic review. BMC Infect Dis2013; 13: 534.
6. S.M.RedmondK.Alexander-KissligS.C.Woodhall. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One2015; 10: e0115753.
7. P.M.MitchellL.F.WhiteL.M.Rahimi. Predictors of gonorrhea and chlamydia in emergency department patients. Ann Emerg Med2012; 60: S119.
8. C.L.AlthausJ.C.HeijneN.Low. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. Sex Transm Dis2012; 39: 402–404.
9. T.C.QuinnC.GaydosM.Shepherd. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA1996; 276: 1737–1742.
10. K.D.EverettR.M.BushA.A.Andersen. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol1999; 49: 415–440.
11. K.SachseP.M.BavoilB.Kaltenboeck. Emendation of the family Chlamydiaceae: proposal of a single genus, Chlamydia, to include all currently recognized species. Syst Appl Microbiol2015; 38: 99–103.
12. M.MolanoC.J.MeijerE.Weiderpass. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis2005; 191: 907–916.
13. S.A.MorreA.J.van den BruleL.Rozendaal. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS2002; 13: 12–18.
14. C.D.BevanB.J.JohalG.Mumtaz. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol1995; 102: 407–414.
15. R.MorcosN.FrostM.Hnat. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J Reprod Med1993; 38: 53–56.
16. Recommendations arising from the 31st Study Group: The Prevention of Pelvic Infection. London; RCOG Press, 1996, pp. 267–270
17. C.K.KentJ.K.ChawW.Wong. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis2005; 41: 67–74.
18. J.F.BoisvertL.A.KoutskyR.J.Suchland. Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men. Sex Transm Dis1999; 26: 392–398.
19. T.C.QuinnS.E.GoodellE.Mkrtichian. Chlamydia trachomatis proctitis. New Engl J Med1981; 305: 195–200.
20. J.L.MarcusK.T.BernsteinS.C.Stephens. Sentinel surveillance of rectal chlamydia and gonorrhea among males – San Francisco, 2005–2008. Sex Transm Dis2010; 37: 59–61.
21. L.PinskyD.B.ChiarilliJ.D.Klausner. Rates of asymptomatic nonurethral gonorrhea and chlamydia in a population of university men who have sex with men. J Am Coll Health2012; 60: 481–484.
22. G.A.F.S.Van LiereC.J.P.A.HoebeN.H.T.M.Dukers-Muijrers. Evaluation of the anatomical site distribution of chlamydia and gonorrhoea in men who have sex with men and in high-risk women by routine testing: Cross-sectional study revealing missed opportunities for treatment strategies. Sex Transm Infect2014; 90: 58–60.
23. G.A.van LiereC.J.HoebeP.F.Wolffs. High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis2014; 14: 274.
24. M.S.van RooijenM.F.Schim van der LoeffS.A.Morre. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sex Transm Infect2015; 91: 157–164.
25. J.ParkJ.L.MarcusM.Pandori. Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men – San Francisco, 2010. Sex Transm Dis2012; 39: 482–484.
26. L.A.BarbeeJ.C.DombrowskiR.Kerani. Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients. Sex Transm Dis2014; 41: 168–172.
27. B.R.JonesM.K.Al-HussainiE.M.Dunlop. Infection of the eye and the genital tract by Tric agent. Br J Vener Dis1964; 40: 19–24.
28. V.H.HuE.M.Harding-EschM.J.Burton. Epidemiology and control of trachoma: Systematic review. Trop Med Int Health2010; 15: 673–691.
29. T.Darville. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis2005; 16: 235–244.
30. M.R.Hammerschlag. Chlamydial infections. J Pediatr1989; 114: 727–734.
31. R.Martin-IguacelJ.M.LlibreH.Nielsen. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis2010; 29: 917–925.
32. R.F.NieuwenhuisJ.M.OssewaardeH.M.Götz. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have with men. Clin Infect Dis2004; 39: 996–1003.
33. A.AhdootD.P.KotlerJ.S.Suh. Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. J Clin Gastroenterol2006; 40: 385–390.
34. H.JebbariS.AlexanderH.Ward. Update on lymphogranuloma venereum in the United Kingdom. Sex Transm Infect2007; 83: 324–326.
35. M.J.van de Laar. The emergence of LGV in Western Europe: what do we know, what can we do?Euro Surveill2006; 11: 146–148.
36. J.A.White. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis2009; 22: 57–66.
37. S.HoieL.S.KnudsenJ.Gerstoft. Lymphogranuloma venereum proctitis: a differential diagnose to inflammatory bowel disease. Scand J Gastroenterol2011; 46: 503–510.
38. E.LanjouwP.L.van DaeleM.P.Raes. Consecutively acquired sexually transmitted infections mimicking Crohn's disease. Am J Gastroenterol2009; 104: 532–533.
39. N.H.de VriezeM.van RooijenM.F.Schim van der Loeff. Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, The Netherlands: trends over time, symptomatology and concurrent infections. Sex Transm Infect2013; 89: 548–552.
40. H.J.de VriesA.ZingoniA.Kreuter. 2013 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol2015; 29: 1–6.
41. W.E.StammM.E.GuinanC.Johnson. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. New Engl J Med1984; 310: 545–549.
42. E.Rees. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol1980; 138: 1042–1047.
43. M.L.RekartM.GilbertR.Meza. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis2013; 207: 30–38.
44. N.BenderB.HerrmannB.Andersen. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect2011; 87: 601–608.
45. C.E.FrenchG.HughesA.Nicholson. Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis2011; 38: 158–162.
46. C.BjartlingS.OsserK.Persson. The frequency of salpingitis and ectopic pregnancy as epidemiologic markers of Chlamydia trachomatis. Acta Obstet Gynecol Scand2000; 79: 123–128.
47. E.J.AdamsK.M.E.TurnerW.J.Edmunds. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect2007; 83: 267–274. discussion 274–275.
48. I.G.van ValkengoedS.A.MorreA.J.van den Brule. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes – implications for cost-effectiveness analyses. Int J Epidemiol2004; 33: 416–425.
49. J.A.LandJ.E.A.M.Van BergenS.A.Morre. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update2010; 16: 189–204.
50. P.OakeshottS.KerryA.Aghaizu. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ2010; 340: c1642.
51. K.KavanaghL.A.WallaceC.Robertson. Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. Int J Epidemiol2013; 42: 493–503.
52. M.TrentD.BassR.B.Ness. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis2011; 38: 879–881.
53. L.WestromR.JoesoefG.Reynolds. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis1992; 19: 185–192.
54. J.M.ChowM.L.YonekuraG.A.Richwald. The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA1990; 263: 3164–3167.
55. A.MiettinenP.K.HeinonenK.Teisala. Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis1990; 17: 10–14.
56. R.B.NessG.TrautmannH.E.Richter. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol2005; 106: 573–580.
57. J.RossP.JudlinJ.Jensen. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS2014; 25: 1–7.
58. US Centers for Disease Control and Prevention. Male chlamydia screening consultation Atlanta, Georgia, 28–29 March 2006, http://www.cdc.gov/std/chlamydia/chlamydiascreening-males.pdf (2007, accessed 15 August 2015)
59. G.BezoldJ.A.PolitchN.B.Kiviat. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril2007; 87: 1087–1097.
60. G.A.GreendaleS.T.HaasK.Holbrook. The relationship of Chlamydia trachomatis infection and male infertility. Am J Public Health1993; 83: 996–1001.
61. P.Joki-KorpelaN.SahrakorpiM.Halttunen. The role of Chlamydia trachomatis infection in male infertility. Fertil Steril2009; 91: 1448–1450.
62. J.D.CarterA.P.Hudson. The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol2010; 22: 424–430.
63. D.Taylor-RobinsonA.Keat. Observations on Chlamydia trachomatis and other microbes in reactive arthritis. Int J STD AIDS2015; 26: 139–144.
64. J.BojovicN.StrelicL.Pavlica. Reiter's syndrome – disease of young men – analysis of 312 patients. Med Pregl2014; 67: 222–230.
65. E.M.CarlinJ.M.ZizaA.Keat. 2014 European Guideline on the management of sexually acquired reactive arthritis. Int J STD AIDS2014; 25: 901–912.
66. R.L.CookS.L.HutchisonL.Ostergaard. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med2005; 142: 914–925.
67. E.J.WatsonA.TempletonI.Russell. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol2002; 51: 1021–1031.
68. S.SkidmoreP.HornerH.Mallinson. Testing specimens for Chlamydia trachomatis. Sex Transm Infect2006; 82: 272–275.
69. S.SkidmoreP.HornerA.Herring. Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?J Clin Microbiol2006; 44: 4389–4394.
70. H.S.ChoeD.S.LeeS.J.Lee. Performance of Anyplex II multiplex real-time PCR for the diagnosis of seven sexually transmitted infections: comparison with currently available methods. Int J Infect Dis2013; 17: e1134–e1140.
71. F.GimenesF.S.MedinaA.L.Abreu. Sensitive simultaneous detection of seven sexually transmitted agents in semen by multiplex-PCR and of HPV by single PCR. PLoS One2014; 9: e98862.
72. R TMA, and ProbeTec ET SDA assays. Eur J Microbiol Immunol (Bp)2012; 2: 121–127.
73. C.Le RoyI.Le HenM.Clerc. The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J Microbiol Meth2012; 89: 193–197.
74. L.M.MushanskiK.BrandtN.Coffin. Comparison of the BD viper system with XTR technology to the Gen-Probe APTIMA COMBO 2 assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens. Sex Transm Dis2012; 39: 514–517.
75. J.SchachterJ.M.ChowH.Howard. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J Clin Microbiol2006; 44: 2512–2517.
76. J.J.van der HelmC.J.HoebeM.S.van Rooijen. High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex Transm Dis2009; 36: 493–497.
77. A.ChengQ.F.QianJ.E.Kirby. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay. J Clin Microbiol2011; 49: 1294–1300.
78. K.A.WorkowskiG.A.Bolan. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015; 64: 1–137.
79. M.UnemoA.RossouwV.James. Can the Swedish new variant of Chlamydia trachomatis (nvCT) be detected by UK NEQAS participants from seventeen European countries and five additional countries/regions in 2009?Euro Surveill2009; 14: pii: 19206.
80. U.ReischlE.StraubeM.Unemo. The Swedish new variant of Chlamydia trachomatis (nvCT) remains undetected by many European laboratories as revealed in the recent PCR/NAT ring trial organised by INSTAND e.V., Germany. Euro Surveill2009; 14: pii: 19302.
81. E.ShipitsynaE.ZolotoverkhayaI.Agne-Stadling. First evaluation of six nucleic acid amplification tests widely used in the diagnosis of Chlamydia trachomatis in Russia. J Eur Acad Dermatol Venereol2009; 23: 268–276.
82. T.RipaP.Nilsson. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill2006; 11: E061109 2.
83. M.UnemoH.M.Seth-SmithL.T.Cutcliffe. The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology2010; 156: 1394–1404.
84. M.UnemoI.N.Clarke. The Swedish new variant of Chlamydia trachomatis. Curr Opin Infect Dis2011; 24: 62–69.
85. L.Van DommelenF.H.Van TielS.Ouburg. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Clin Microbiol Infect2010; 16: S560.
86. J.J.van der HelmL.O.SabajoA.W.Grunberg. Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname. PLoS One2012; 7: e32122.
87. M.K.Libbus. Chlamydia Rapid Test was moderately accurate for diagnosing Chlamydia infection in women. Evid Based Nurs2008; 11: 89.
88. J.HislopZ.QuayyumG.Flett. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men Review. Health Technol Assess2010; 14: 1–97. (iii–iv).
89. S.Skidmore. Poorly performing point-of-care tests for chlamydia: What can be done?Sex Transm Infect2010; 86: 330.
90. L.Mahilum-TapayV.LaitilaJ.J.Wawrzyniak. New point of care Chlamydia Rapid Test -- bridging the gap between diagnosis and treatment: performance evaluation study. BMJ2007; 335: 1190–1194.
91. E.C.NadalaB.T.GohJ.P.Magbanua. Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study. BMJ2009; 339: b2655.
92. W.HuangC.A.GaydosM.R.Barnes. Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex Transm Infect2013; 89: 108–114.
93. C.A.GaydosB.Van Der PolM.Jett-Goheen. Performance of the Cepheid CT/NG Xpert Rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol2013; 51: 1666–1672.
94. C.A.WisniewskiJ.A.WhiteC.E.Michel. Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men. J Clin Microbiol2008; 46: 1466–1469.
95. D.ManginD.MurdochJ.E.Wells. Chlamydia trachomatis testing sensitivity in midstream compared with first-void urine specimens. Ann Fam Med2012; 10: 50–53.
96. C.E.MichelC.SonnexC.A.Carne. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol2007; 45: 1395–1402.
97. J.LiD.JangJ.Gilchrist. Comparison of flocked and Aptima swabs and two specimen transport media in the Aptima Combo 2 assay. J Clin Microbiol2014; 52: 3808–3809.
98. S.BialasiewiczD.M.WhileyM.Buhrer-Skinner. A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatis. Sex Transm Infect2009; 85: 102–105.
99. A.S.GraseckS.L.ShihJ.F.Peipert. Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Rev Anti Infect Ther2011; 9: 183–194.
100. M.E.SextonJ.J.BakerK.Nakagawa. How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men?J Fam Pract2013; 62: 70–78.
101. M.SextonJ.BakerR.Perkins. Self-administered Neisseria gonorrhoeae and Chlamydia trachomatis testing in the pharynx and rectum among men who have sex with men in Washington, DC. Sex Transm Infect2011; 87: A74–AA5.
102. S.AlexanderC.IsonJ.Parry. Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex Transm Infect2008; 84: 488–492.
103. C.M.Holland-HallH.C.WiesenfeldP.J.Murray. Self-collected vaginal swabs for the detection of multiple sexually transmitted infections in adolescent girls. J Pediatr Adolesc Gynecol2002; 15: 307–313.
104. J.FangC.HusmanL.DeSilva. Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol2008; 21: 355–360.
105. J.SchachterM.A.CherneskyD.E.Willis. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis2005; 32: 725–728.
106. M.A.CherneskyE.W.Hook3rdD.H.Martin. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis2005; 32: 729–733.
107. M.M.HobbsB.van der PolP.Totten. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis2008; 35: 8–13.
108. C.A.GaydosC.FarshyM.Barnes. Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?Diagn Microbiol Infect Dis2012; 73: 16–20.
109. V.A.FitzhughD.S.Heller. Significance of a diagnosis of microorganisms on pap smear. J Low Genit Tract Dis2008; 12: 40–51.
110. M.CherneskyD.JangE.Portillo. Detection of Chlamydia trachomatis in SurePath™ liquid-based Pap samples using Aptima Combo 2™, AMPLICOR™ and ProbeTec™ assays. Can J Infect Dis Med Microbiol2010; 21: 10A.
111. T.E.PittarasJ.Papaparaskevas. Comparison of penile skin swab with intra-urethral swab and first void urine for polymerase chain reaction-based diagnosis of Chlamydia trachomatis urethritis in male patients. Sex Transm Dis2008; 35: 999–1001.
112. S.P.JebakumarC.StoreyM.Lusher. Value of screening for oro-pharyngeal Chlamydia trachomatis infection. J Clin Path1995; 48: 658–661.
113. M.R.HammerschlagP.M.RoblinM.Gelling. Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis. Pediatr Infect Dis J1997; 16: 293–297.
114. K.V.OtaI.E.TamariM.Smieja. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex Transm Infect2009; 85: 182–186.
115. R.P.H.PetersS.P.VerweijN.Nijsten. Evaluation of sexual history-based screening of anatomic sites for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men having sex with men in routine practice. BMC Infect Dis2011; 11: 203.
116. C.TippleS.C.HillA.Smith. Is screening for pharyngeal Chlamydia trachomatis warranted in high-risk groups?Int J STD AIDS2010; 21: 770–771.
117. J.L.MarcusK.T.BernsteinR.P.Kohn. Infections missed by urethral-only screening for Chlamydia or Gonorrhea detection among men who have sex with men. Sex Transm Dis2011; 38: 922–924.
118. J.SchachterJ.MoncadaS.Liska. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis2008; 35: 637–642.
119. S.AlexanderI.MartinC.Ison. Confirming the Chlamydia trachomatis status of referred rectal specimens. Sex Transm Infect2007; 83: 327–329.
120. M.J.MimiagaK.H.MayerS.L.Reisner. Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men. Sex Transm Dis2008; 35: 495–498.
121. L.H.BachmannR.E.JohnsonH.Cheng. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol2010; 48: 1827–1832.
122. H.WardH.J.C.de VriesM.van de Laar. Re-emergence of lymphogranuloma venereum in Europe and the public health response. Sex Transm Infect2011; 87: A19–A20.
123. H.WardI.MartinN.Macdonald. Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis2007; 44: 26–32.
124. H.J.de VriesA.ZingoniJ.A.White. 2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS2013; 25: 465–474.
125. R.GdouraW.KchaouL.Ammar-Keskes. Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl2008; 29: 198–206.
126. F.Hamdad-DaoudiJ.PetitF.Eb. Assessment of Chlamydia trachomatis infection in asymptomatic male partners of infertile couples. J Med Microbiol2004; 53: 985–990.
127. Y.PannekoekS.M.WestenbergP.P.Eijk. Assessment of Chlamydia trachomatis infection of semen specimens by ligase chain reaction. J Med Microbiol2003; 52: 777–779.
128. E.M.van der SnoekJ.M.OssewaardeW.I.van der Meijden. The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis. Sex Transm Infect2007; 83: 330–334.
129. H.J.de VriesV.SmelovS.Ouburg. Anal lymphogranuloma venereum infection screening with IgA anti-Chlamydia trachomatis-specific major outer membrane protein serology. Sex Transm Dis2010; 37: 789–795.
130. S.P.VerweijE.LanjouwC.J.Bax. Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections. BMC Infect Dis2014; 14: 3.
131. A.P.GijsenJ.A.LandV.J.Goossens. Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time. Hum Reprod2002; 17: 699–703.
132. C.M.Black. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev1997; 10: 160–184.
133. R.C.SheR.WelchA.R.Wilson. Correlation of Chlamydia and Chlamydophila spp. IgG and IgM antibodies by microimmunofluorescence with antigen detection methods. J Clin Lab Anal2011; 25: 305–308.
134. A.CladH.M.FreidankM.Kunze. Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur J Clin Microbiol Infect Dis2000; 19: 932–937.
135. J.W.MoutonM.F.PeetersJ.H.van Rijssort-Vos. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology. Int J STD AIDS2002; 13: 26–29.
136. R.P.VerkooyenM.F.PeetersJ.H.van Rijsoort-Vos. Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests. Int J STD AIDS2002; 13: 23–25.
137. J.A.LandJ.L.Evers. Chlamydia infection and subfertility. Best Pract Res Clin Obstet Gynaecol2002; 16: 901–912.
138. E.LanjouwJ.M.OssewaardeA.Stary. 2010 European guideline for the management of Chlamydia trachomatis infections. Int J STD AIDS2010; 21: 729–737.
139. Ministry of Health, Wellington, New Zealand. Chlamydia Management Guidelines 2008, https://www.health.govt.nz/system/files/documents/publications/chlamydia-management-guidelines.pdf (2008, accessed 15 August 2015)
140. M.FungK.C.ScottC.K.Kent. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect2007; 83: 304–309.
141. Scottish Intercollegiate Guidelines Network (SIGN). Management of genital Chlamydia trachomatis infection. A national clinical guideline, http://www.sign.ac.uk/pdf/sign109.pdf (2009, accessed 15 August 2015)
142. Public Health Agency of Canada. Canadian Guidelines on sexually transmitted infection, http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/index-eng.php (accessed 15 August 2015)
143. Health Protection Agency. National Chlamydia Screening Programme (2010), UK: National Chlamydia Screening Programme, 2010.
144. C.B.HosenfeldK.A.WorkowskiS.Berman. Repeat infection with chlamydia and gonorrhea among females: A systematic review of the literature. Sex Transm Dis2009; 36: 478–489.
145. Royal Australian College of General Practitioners. Guidelines for Preventive Activities in General Practice, 8th ed. http://www.racgp.org.au/download/Documents/Guidelines/Redbook8/redbook8.pdf (accessed 15 August 2015)
146. Public Health England. National Chlamydia screening programme, http://www.chlamydiascreening.nhs.uk/ps/news.asp (accessed 15 August 2015)
147. M.J.van de LaarJ.Fontaine. ECDC guidance on chlamydia control in Europe: next steps. Euro Surveill2009; 14: pii: 19260.
148. D.G.ReganD.P.WilsonJ.S.Hocking. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis2008; 198: 349–358.
149. J.W.GlasserK.Owusu-EduseiS.N.Glick. Controlling chlamydia: population modeling to assess promising interventions. Sex Transm Infect2013; 89: A57.
150. C.L.AlthausJ.C.HeijneS.A.Herzog. Individual and population level effects of partner notification for Chlamydia trachomatis. PLoS ONE2012; 7: e51438.
151. M.S.JamilH.M.BauerJ.S.Hocking. Chlamydia screening strategies and outcomes in educational settings: A systematic review. Sex Transm Dis2014; 41: 180–187.
152. D.ScholesA.StergachisF.E.Heidrich. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. New Engl J Med1996; 334: 1362–1366.
153. L.OstergaardB.AndersenJ.K.Moller. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis2000; 31: 951–957.
154. B.AndersenI.van ValkengoedI.Sokolowski. Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Sex Transm Infect2011; 87: 156–161.
155. J.C.HeijneS.A.HerzogC.L.Althaus. Insights into the timing of repeated testing after treatment for Chlamydia trachomatis: data and modelling study. Sex Transm Infect2013; 89: 57–62.
156. A.AghaizuF.ReidS.Kerry. Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study. Sex Transm Infect2014; 90: 524–528.
157. British Association for Sexual Health and HIV. Chlamydia trachomatis UK testing guidelines. 2010. http://www.bashh.org/documents/3352.pdf (accessed 15 August 2015)
158. D.Scott LamontagneK.BasterL.Emmett. Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect2007; 83: 292–303.
159. Public Health England. 2013. Position Statement. NCSP Recommended Case Management Change: Routine offer of re-test to young adults testing positive for chlamydia, http://www.chlamydiascreening.nhs.uk/ps/resources/re-testing/NCSP%20Position%20Statement_e-testing%20of%20Positive%20Chlamydia%20Cases_August%202013_FINAL.pdf (accessed 15 August 2015)
160. British Association of Sexual Health and HIV. 2014 Draft UK national guideline for the management of genital infection with Chlamydia trachomatis, http://www.bashh.org/BASHH/Guidelines/Guidelines/BASHH/Guidelines/Guidelines.aspx?hkey=072c83ed-0e9b-44b2-a989-7c84e4fbd9de (2013, accessed 15 August 2015)
161. P.J.Horner. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. Sex Transm Infect2012; 88: 154–156.
162. K.M.SandozD.D.Rockey. Antibiotic resistance in Chlamydiae. Future Microbiol2010; 5: 1427–1442.
163. S.A.WangJ.R.PappW.E.StammR.W.PeelingD.H.MartinK.K.Holmes. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis2005; 191: 917–923.
164. C.E.O'NeillH.M.Seth-SmithB.Van Der Pol. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology2013; 159: 748–756.
165. H.H.Handsfield. Questioning azithromycin for chlamydial infection. Sex Transm Dis2011; 38: 1028–1029.
166. J.R.SchwebkeA.RompaloS.Taylor. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis2011; 52: 163–170.
167. A.C.SenaS.LensingA.Rompalo. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis2012; 206: 357–365.
168. F.Y.KongJ.S.Hocking. Treatment challenges for urogenital and anorectal Chlamydia trachomatis. BMC Infect Dis2015; 15: 293.
169. J.SomaniV.B.BhullarK.A.Workowski. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis2000; 181: 1421–1427.
170. A.R.BhengrajP.SrivastavaA.Mittal. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin. Int J Antimicrob Agent2011; 38: 178–179.
171. P.MpigaM.Ravaoarinoro. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int J Antimicrob Agent2006; 27: 316–324.
172. G.W.Amsden. Erythromycin, clarithromycin, and azithromycin: are the differences real?Clin Ther1996; 18: 56–72. discussion 55.
173. H.LodeK.BornerP.Koeppe. Azithromycin--review of key chemical, pharmacokinetic and microbiological features. J Antimicrob Chemother1996; 37: 1–8.
174. E.BjorneliusC.AnagriusG.Bojs. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect2008; 84: 72–76.
175. C.AnagriusB.LoreJ.S.Jensen. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PloS One2013; 8: e61481.
176. P.HornerK.BleeE.Adams. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!. Curr Opin Infect Dis2014; 27: 68–74.
177. D.Taylor-RobinsonJ.S.Jensen. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev2011; 24: 498–514.
178. M.UnemoK.M.A.EndreH.Moi. Five-day azithromycin treatment regimen for Mycoplasma genitalium infection also effectively eradicates Chlamydia trachomatis. Acta Derm Venereol2015. 95: 730--732.
179. F.Y.KongS.N.TabriziM.Law. Azithromycin versus doxycycline for the treatment of genital Chlamydia infection: A meta-analysis of randomized controlled trials. Clin Infect Dis2014; 59: 193–205.
180. H.H.IbsenB.R.MollerL.Halkier-Sorensen. Treatment of nongonococcal urethritis: comparison of ofloxacin and erythromycin. Sex Transm Dis1989; 16: 32–35.
181. H.MaitiF.H.ChowdhuryS.J.Richmond. Ofloxacin in the treatment of uncomplicated gonorrhea and chlamydial genital infection. Clin Ther1991; 13: 441–447.
182. S.TakahashiK.IchiharaJ.Hashimoto. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother2011; 17: 392–396.
183. M.CramersP.KaspersenE.From. Pivampicillin compared with erythromycin for treating women with genital Chlamydia trachomatis infection. Genitourin Med1988; 64: 247–248.
184. A.M.WormG.HoffS.Kroon. Roxithromycin compared with erythromycin against genitourinary chlamydial infections. Genitourin Med1989; 65: 35–38.
185. A.A.KhrianinO.V.Reshetnikov. [Is it safe to use josamycin in the obstetrics practice in Russia?]. Antibiot Khimioter2007; 52: 32–36. [In Russian].
186. F.M.PrimieroG.CarusoF.Grottanelli. Josamycin in the treatment of Chlamydia trachomatis cervicitis. J Chemother1989; 1: 909–910.
187. A.LucisanoA.M.VitaleB.Cinque. Josamycin in the treatment of chlamydial genital infections in infertile women. J Chemother1989; 1: 906–908.
188. N.M.SteedmanA.McMillan. Treatment of asymptomatic rectal Chlamydia trachomatis: Is single-dose azithromycin effective?Int J STD AIDS2009; 20: 16–18.
189. A.ElgalibS.AlexanderC.Y.W.Tong. Seven days of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection. Int J STD AIDS2011; 22: 474–477.
190. E.HathornC.OpieP.Goold. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women?Sex Transm Infect2012; 88: 352–354.
191. C.M.KhosropourJ.C.DombrowskiL.A.Barbee. Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: A retrospective cohort study. Sex Transm Dis2014; 41: 79–85.
192. F.DrummondN.RyderH.Wand. Is azithromycin adequate treatment for asymptomatic rectal chlamydia?Int J STD AIDS2011; 22: 478–480.
193. British Association for Sexual Health and HIV. UK national guideline for the management of genital tract infection with Chlamydia trachomatis. http://www.bashh.org/documents/65.pdf (2006, accessed 15 August 2015)
194. E.PitsouniC.IavazzoS.Athanasiou. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agent2007; 30: 213–221.
195. L.RahangdaleS.GuerryH.M.Bauer. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis2006; 33: 106–110.
196. M.SarkarC.WoodlandG.Koren. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth2006; 6: 18.
197. E.J.PostemaL.RemeijerW.I.van der Meijden. Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis: a retrospective study. Genitourin Med1996; 72: 203–205.
198. G.SulisL.UrbinatiA.Franzoni. Chlamydia trachomatis conjunctivitis in a male teenager: a case report. Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive2014; 22: 140–143.
199. Members AAoO-CEDP. Preferred practice pattern guidelines: conjunctivitis – limited revision, 20112014.
200. T.E.WilsonM.HogbenE.S.Malka. A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health2009; 99: S104–S110.
201. M.HogbenP.Kissinger. A review of partner notification for sex partners of men infected with chlamydia. Sex Transm Dis2008; 35: S34–S39.
202. Tiplica GS, Evans C, Gomberg M, et al. 2013 European guidelines for the management of partners of persons with sexually transmitted infections. http://www.iusti.org/regions/europe/word_docs/17.1_European_guideline_on_PN.doc (2013, accessed 15 August 2015)
203. H.McIlveen. Review: partner notification interventions can reduce persistent or recurrent sexually transmitted infections. Evidence Based Nursing2007; 10: 107.
204. H.McCleanC.A.CarneA.K.Sullivan. Chlamydial partner notification in the British Association for Sexual Health and HIV (BASHH) 2011 UK national audit against the BASHH Medical Foundation for AIDS and Sexual Health Sexually Transmitted Infections Management Standards. Int J STD AIDS2012; 23: 748–752.
205. W.M.Geisler. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis2010; 201: S104–S113.
206. W.M.Geisler. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis2007; 44: S77–S83.
207. G.BellJ.Potterat. Partner notification for sexually transmitted infections in the modern world: A practitioner perspective on challenges and opportunities. Sex Transm Infect2011; 87: ii34–ii6.
208. A.FerreiraT.YoungC.Mathews. Strategies for partner notification for sexually transmitted infections, including HIV. [Update of Cochrane Database Syst Rev 2001; (4): CD002843; PMID: 11687164]. Cochrane Database Syst Rev2013; 10: CD002843.
209. C.L.AlthausK.M.E.TurnerC.H.Mercer. Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: Observational study, systematic reviews and mathematical modelling. Health Technol Assess2014; 18: 1–99.
210. N.L.PavlinR.M.ParkerA.K.Piggin. Better than nothing? Patient-delivered partner therapy and partner notification for chlamydia: The views of Australian general practitioners. BMC Infect Dis2009; 10: 274.
211. M.HogbenS.KiddG.R.Burstein. Expedited partner therapy for sexually transmitted infections. Curr Opin Obstet Gynecol2012; 24: 299–304.
212. N.H.Dukers-MuijrersS.A.MorreA.Speksnijder. Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. PLoS ONE2012; 7: e34108.
213. C.A.RenaultD.M.IsraelskiV.Levy. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection. Sex Health2011; 8: 69–73.
214. P.JudlinQ.LiaoZ.Liu. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG2010; 117: 1475–1484.